Rony Pain is dedicated to addressing the significant issue of cancer metastasis, responsible for approximately 90% of cancer-related deaths. His research focuses on PCLX-001, an investigational drug shown to inhibit the metabolism of aggressive breast cancer cells, potentially preventing their spread and offering a promising solution to the metastasis problem, ultimately benefiting numerous patients facing aggressive and lethal cancers.
*Due to technical difficulties, a small portion of the pitch is unavailable. 

Further Activities to have a look at